| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 15.91% | Jefferies | → $33 | Initiates Coverage On | → Buy |
| 11/01/2023 | 22.94% | Piper Sandler | $32 → $35 | Maintains | Overweight |
| 10/17/2023 | 1.86% | B of A Securities | $32 → $29 | Maintains | Neutral |
| 09/19/2023 | 1.86% | Morgan Stanley | → $29 | Initiates Coverage On | → Equal-Weight |
| 08/03/2023 | 12.4% | Piper Sandler | $25 → $32 | Maintains | Overweight |
| 08/03/2023 | 22.94% | Goldman Sachs | $27 → $35 | Maintains | Buy |
| 08/03/2023 | 12.4% | B of A Securities | $25 → $32 | Downgrades | Buy → Neutral |
| 06/23/2023 | 5.37% | Stephens & Co. | → $30 | Initiates Coverage On | → Equal-Weight |
| 05/04/2023 | 5.37% | Craig-Hallum | $25 → $30 | Maintains | Buy |
| 05/04/2023 | -5.16% | Goldman Sachs | $21 → $27 | Maintains | Buy |
| 05/04/2023 | -8.68% | Wells Fargo | $24 → $26 | Maintains | Overweight |
| 04/18/2023 | -26.24% | Goldman Sachs | $19 → $21 | Maintains | Buy |
| 04/17/2023 | -26.24% | Goldman Sachs | $19 → $21 | Maintains | Buy |
| 04/05/2023 | -12.19% | Craig-Hallum | → $25 | Initiates Coverage On | → Buy |
| 03/09/2023 | -33.26% | Goldman Sachs | $15 → $19 | Maintains | Buy |
| 03/09/2023 | -33.26% | Wells Fargo | $15 → $19 | Maintains | Overweight |
| 03/09/2023 | -40.29% | Credit Suisse | $16 → $17 | Maintains | Outperform |
| 01/03/2023 | -47.31% | Wells Fargo | $12 → $15 | Maintains | Overweight |
| 12/15/2022 | -40.29% | Piper Sandler | $13 → $17 | Maintains | Overweight |
| 11/10/2022 | -57.85% | Wells Fargo | $14 → $12 | Maintains | Overweight |
| 10/03/2022 | -50.83% | Wells Fargo | $15 → $14 | Maintains | Overweight |
| 08/11/2022 | -50.83% | Credit Suisse | $13 → $14 | Maintains | Outperform |
| 07/08/2022 | -57.85% | B of A Securities | → $12 | Upgrades | Neutral → Buy |
| 05/16/2022 | -47.31% | Piper Sandler | $17 → $15 | Maintains | Overweight |
| 05/12/2022 | -47.31% | Goldman Sachs | $17 → $15 | Maintains | Buy |
| 05/12/2022 | -54.34% | Credit Suisse | $14 → $13 | Maintains | Outperform |
| 04/04/2022 | -40.29% | Goldman Sachs | $19 → $17 | Maintains | Buy |
| 03/14/2022 | -64.88% | B of A Securities | $15 → $10 | Downgrades | Buy → Neutral |
| 03/11/2022 | -50.83% | Credit Suisse | $16 → $14 | Maintains | Outperform |
| 03/11/2022 | -61.36% | Wells Fargo | $15 → $11 | Maintains | Overweight |
| 11/15/2021 | -36.78% | Evercore ISI Group | → $18 | Initiates Coverage On | → Outperform |
| 11/15/2021 | -36.78% | Wells Fargo | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2021 | -36.78% | Credit Suisse | → $18 | Initiates Coverage On | → Outperform |
| 11/15/2021 | -40.29% | Piper Sandler | → $17 | Initiates Coverage On | → Overweight |
| 11/15/2021 | -22.73% | Goldman Sachs | → $22 | Initiates Coverage On | → Buy |
What is the target price for Vita Coco (COCO)?
The latest price target for Vita Coco (NASDAQ: COCO) was reported by Jefferies on November 13, 2023. The analyst firm set a price target for $33.00 expecting COCO to rise to within 12 months (a possible 15.91% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vita Coco (COCO)?
The latest analyst rating for Vita Coco (NASDAQ: COCO) was provided by Jefferies, and Vita Coco initiated their buy rating.
When is the next analyst rating going to be posted or updated for Vita Coco (COCO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vita Coco, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vita Coco was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Vita Coco (COCO) correct?
While ratings are subjective and will change, the latest Vita Coco (COCO) rating was a initiated with a price target of $0.00 to $33.00. The current price Vita Coco (COCO) is trading at is $28.47, which is within the analyst's predicted range.